Ubs Group Ag Acrivon Therapeutics, Inc. Transaction History

Ubs Group Ag

  • $400 Billion
  • Q2 2024

A detailed history of Ubs Group Ag transactions in Acrivon Therapeutics, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 11,152 shares of ACRV stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,152
Previous 12,745 12.5%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
SELL
N/A
-1,593 Reduced 12.5%
11,152 $0
Q1 2024

May 13, 2024
BUY
N/A
12,745 New
12,745 $0
Q3 2023

Nov 09, 2023
SELL
N/A
-9,678 Reduced 98.96%
102 $0
Q2 2023

Aug 11, 2023
BUY
N/A
4,384 Added 81.25%
9,780 $0
Q1 2023

May 12, 2023
BUY
N/A
648 Added 13.65%
5,396 $0
Q4 2022

Feb 08, 2023
BUY
N/A
4,748 New
4,748 $0

Others Institutions Holding ACRV

# of Institutions
53
Shares Held
23.7M
Call Options Held
0
Put Options Held
0
View Full List

About Acrivon Therapeutics, Inc.

ACRV Quotes by TradingView
  • Ticker ACRV
More about ACRV
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email